NASDAQ:AMIX Autonomix Medical (AMIX) Stock Price, News & Analysis $6.76 +0.33 (+5.13%) Closing price 04:00 PM EasternExtended Trading$6.69 -0.07 (-0.98%) As of 06:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock About Autonomix Medical Stock (NASDAQ:AMIX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Autonomix Medical alerts:Sign Up Key Stats Today's Range$6.37▼$6.8650-Day Range$5.72▼$8.7852-Week Range$4.20▼$55.44Volume7,106 shsAverage Volume17,587 shsMarket Capitalization$3.65 millionP/E RatioN/ADividend YieldN/APrice Target$42.00Consensus RatingHold Company Overview Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas. Read More Autonomix Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks50th Percentile Overall ScoreAMIX MarketRank™: Autonomix Medical scored higher than 50% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.4 / 5Analyst RatingHold Consensus RatingAutonomix Medical has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, 1 hold rating, and 1 sell rating.Upside PotentialAutonomix Medical has a consensus price target of $42.00, representing about 521.3% upside from its current price of $6.76.Amount of Analyst CoverageAutonomix Medical has only been the subject of 2 research reports in the past 90 days.Read more about Autonomix Medical's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Autonomix Medical are expected to grow in the coming year, from ($20.17) to ($17.44) per share.Price to Book Value per Share RatioAutonomix Medical has a P/B Ratio of 0.62. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Autonomix Medical's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted5.31% of the float of Autonomix Medical has been sold short.Short Interest Ratio / Days to CoverAutonomix Medical has a short interest ratio ("days to cover") of 2.34, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Autonomix Medical has recently decreased by 46.75%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAutonomix Medical does not currently pay a dividend.Dividend GrowthAutonomix Medical does not have a long track record of dividend growth. News and Social Media0.0 / 5News SentimentN/A News Coverage This WeekMarketBeat has tracked 1 news article for Autonomix Medical this week, compared to 3 articles on an average week.MarketBeat FollowsOnly 1 people have added Autonomix Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days. Company Ownership0.3 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Autonomix Medical insiders have not sold or bought any company stock.Percentage Held by Insiders6.20% of the stock of Autonomix Medical is held by insiders.Percentage Held by Institutions10.78% of the stock of Autonomix Medical is held by institutions.Read more about Autonomix Medical's insider trading history. Receive AMIX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Autonomix Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AMIX Stock News HeadlinesAutonomix Medical, Inc. (NASDAQ:AMIX) Sees Large Decline in Short InterestJune 30, 2026 | americanbankingnews.comAutonomix Medical Enacts 1-for-21 Reverse Stock SplitJune 24, 2026 | tipranks.comThree companies about to leapfrog Nvidia [And transform the entire industry]Tech forecaster George Gilder - who identified Amazon when it was still just an online bookstore and predicted mobile computing years before the iPhone - has identified three companies he calls the 'Trillion Dollar Triangle.' One of them went public just weeks ago. Demand for its technology is already outpacing supply, with major AI players among its biggest customers. Gilder says this kind of supply crunch is the tell that a new technology is transitioning from possibility to inevitability.July 6 at 1:00 AM | Eagle Publishing (Ad)Autonomix Medical Announces Standalone Neural Sensing Program with Evidence of Real-Time Renal Nerve Activity ChangeJune 22, 2026 | globenewswire.comAutonomix Announces Reverse Stock SplitJune 18, 2026 | globenewswire.comAutonomix Medical Announces Release of New CEO Corner Segment Highlighting Global Scientific and Clinical Recognition of Platform TechnologyJune 10, 2026 | globenewswire.comAnalysts Offer Insights on Healthcare Companies: Bioline RX Ltd Sponsored ADR (BLRX), BeOne Medicines (ONC) and Autonomix Medical, Inc. (AMIX)June 5, 2026 | theglobeandmail.comAutonomix Medical Highlights Clinical Data Presented at Society of Surgical Oncology Annual Meeting in Virtual Investor "What This Means" Segment Featuring City of Hope Chief ...June 5, 2026 | markets.businessinsider.comSee More Headlines AMIX Stock Analysis - Frequently Asked Questions How have AMIX shares performed this year? Autonomix Medical's stock was trading at $11.55 at the beginning of the year. Since then, AMIX shares have decreased by 41.5% and is now trading at $6.76. How were Autonomix Medical's earnings last quarter? Autonomix Medical, Inc. (NASDAQ:AMIX) released its earnings results on Wednesday, November, 12th. The company reported ($28.98) earnings per share for the quarter, meeting analysts' consensus estimates of ($28.98). When did Autonomix Medical's stock split? Autonomix Medical shares reverse split on Wednesday, June 24th 2026.A 1-21 reverse split was announced. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, June 23rd 2026. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. When did Autonomix Medical IPO? Autonomix Medical (AMIX) raised $11 million in an initial public offering (IPO) on the week of January 29th 2024. The company issued 2,234,222 shares at a price of $5.00 per share. How do I buy shares of Autonomix Medical? Shares of AMIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Autonomix Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Autonomix Medical investors own include Advanced Micro Devices (AMD), Luminar Technologies (LAZR), New Found Gold (NFGC), Tesla (TSLA), Global X Artificial Intelligence & Technology ETF (AIQ), Aldeyra Therapeutics (ALDX) and Allegro MicroSystems (ALGM). Company Calendar Last Earnings11/12/2025Today7/06/2026Next Earnings (Estimated)8/12/2026Fiscal Year End3/31/2027Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED INSTRUMENTS Sub-IndustryMedical Equipment Current SymbolNASDAQ:AMIX Previous SymbolNASDAQ:AMIX CIK1617867 Webautonomix.com Phone713-588-6150FaxN/AEmployees1Year FoundedN/APrice Target and Rating Average Price Target for Autonomix Medical$42.00 High Price Target$42.00 Low Price Target$42.00 Potential Upside/Downside+521.3%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)($74.58) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$16.72 million Net MarginsN/A Pretax MarginN/A Return on Equity-239.36% Return on Assets-192.46% Debt Debt-to-Equity RatioN/A Current Ratio4.45 Quick Ratio4.45 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$10.85 per share Price / Book0.62Miscellaneous Outstanding Shares540,000Free Float509,000Market Cap$3.65 million OptionableN/A Beta-1.32 Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (NASDAQ:AMIX) was last updated on 7/6/2026 by MarketBeat.com Staff. From Our PartnersAmazon, Google, Meta, and Microsoft just committed $700 billionAmazon, Google, Meta, and Microsoft have committed $700 billion this year alone to AI infrastructure - more th...True Market Insiders | SponsoredThree companies about to leapfrog Nvidia [And transform the entire industry]Tech forecaster George Gilder - who identified Amazon when it was still just an online bookstore and predicted...Eagle Publishing | SponsoredBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...Chaikin Analytics | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredThe Starlink of EnergyA portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...Monument Traders Alliance | SponsoredThe Warsh Fed and what it could mean for your savingsThe Fed just changed hands, and Reagan Gold Group says there may be a short window before the impact shows up ...Reagan Gold Group | SponsoredElon’s New Currency (BUY NOW)Elon Musk is reportedly launching a currency system that analysts say could target a $480 trillion market disr...InvestorPlace | SponsoredMove your money (NOT into the next AI IPO)While headlines focus on AI IPOs, the world's largest investors are moving capital into one asset at the faste...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Autonomix Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Autonomix Medical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.